Quietly turning point in the parity pharmacy.doc

 PAGE \* MERGEFORMAT 10 Quietly turning point in the parity pharmacy Has been touted as among the numerous cheap pharmacy medicine has recently not much discourage the market added to the suit, there has been virtually a typical review, although the industry reluctant to parity with the market to do business pharmacy negative evaluation, while the ‘parity’ word as an objective in the pharmaceutical monopoly play ice-breaking role, they still expect the market can give a certain return, but the ‘grass head doctor’ still could not withstand the hospital melee, in the hot after a while, many of the problems exposed a direct impact on market share of the parity-based scheme, the resulting range of issues need to give in order to focus on. Thinking of the power of parity Parity as a pretext that has been cut into the market, doubts that consumers concerned about the significance of parity in the end to have the length of bearing, is being considered in Chinese medicine pharmacy chain into the first question, as a passive carrier of consumption, pharmacies play a role in its focus on what is place on the parity in the timing seems to have had an objective validation of results. OTC spending most of the major or the continuation of the disease, the test of time consumers have become increasingly impatient, we usually see is a less medication, and hanging the phenomenon of more needles, infusion Hall’s head fibrillation, is a consumer phenomenon of feedback, the resulting phenomenon is the turning point in the relationship between medicine. Parity is generated in a specific context of a conduct of operations, is largely a marketing tool to another, is not able to parity as an open and chain dominate the market theme, the current parity is actually a kind of sales approach can not be compared , how much power parity in the end be able to continue to maintain its existing consumer beliefs, needs analysis. The key role of the parity pharmacy must be based on parity b